[Pubmed] Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respirat
Posté : 25 janv. 2022 12:00
Isr Med Assoc J. 2022 Jan;24(1):9-10.
ABSTRACT
The Oxford-AstraZeneca vaccine ChAdOx1 (AZD1222, Vaxzevria) is playing a crucial role in counteracting the coronavirus disease-2019 (COVID-19) pandemic [1]. Since March 2021, reports of unexpected thrombotic events associated with thrombocytopenia and vaccination have been published [2]. To the best of our knowledge there is only one report about vaccination-associated myasthenia gravis (MG) occurring after a second dose of BNT162b2 (Pfizer-BioNTech).
PMID:35077038
Source: https://pubmed.ncbi.nlm.nih.gov/3507703 ... 2&v=2.17.5